デフォルト表紙
市場調査レポート
商品コード
1304089

眼科市場:疾患別、製品タイプ別、エンドユーザー別 - 2023年~2030年の世界予測

Ophthalmology Market by Diseases, Product Type, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 196 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
眼科市場:疾患別、製品タイプ別、エンドユーザー別 - 2023年~2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の眼科の市場規模は、2023年に599億米ドルとなり、CAGR6.63%で大きく成長し、2030年までに驚異的な939億9,000万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の眼科市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.眼科の世界市場規模および予測は?

2.予測期間中、眼科の世界市場を形成するCOVID-19の阻害要因と影響は?

3.眼科の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?

4.眼科の世界市場における競争戦略は?

5.眼科の世界市場における技術動向と規制の枠組みは?

6.眼科の世界市場における主要ベンダーの市場シェアは?

7.眼科の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 眼疾患の有病率の上昇と国民の間での意識の高まり
      • 度付きメガネとレンズの採用の増加
      • 設備の整ったヘルスケアインフラの存在と医薬品承認数の増加
    • 抑制要因
      • 高額な眼科治療費
    • 機会
      • 眼科治療に関する新たな調査活動と助成金の利用可能性
      • 眼科の技術統合による高い使用可能性
    • 課題
      • 眼科処置の熟練専門家の不足
  • 市場動向
    • 遠隔医療の出現と南北アメリカ全土での眼科ケアの拡大
    • アジア太平洋における失明や視覚障害の蔓延によりニーズが高まっている眼科医薬品の開発に注力する新興企業
    • 欧州・中東・アフリカにおける眼科治療薬の調査活動の急増と継続的な技術進歩
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 眼科市場:疾患別

  • 加齢性黄斑変性症
  • 白内障
  • 緑内障
  • 炎症性疾患
  • 屈折障害

第7章 眼科市場:製品タイプ別

  • 薬物
    • アレルギー性結膜炎および炎症薬
    • ドライアイ治療薬
    • 緑内障治療薬
    • 網膜障害治療薬
  • 器具
    • 診断装置
    • 外科用器具
      • 眼内レンズ
      • 眼科用レーザー
  • 度付きメガネとレンズ
  • ソフトウェア

第8章 眼科市場:エンドユーザー別

  • ヘルスケアサービスプロバイダー
  • 病院
  • 医療機関
  • 研究機関

第9章 南北アメリカの眼科市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の眼科市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの眼科市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別
    • 合併・買収
    • 契約、コラボレーション、パートナーシップ
    • 新製品発売と機能強化
    • 投資、資金調達
    • 受賞・表彰・拡大

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. OPHTHALMOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. OPHTHALMOLOGY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. OPHTHALMOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2022 VS 2030 (%)
  • FIGURE 5. OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
  • FIGURE 6. OPHTHALMOLOGY MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 7. OPHTHALMOLOGY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. OPHTHALMOLOGY MARKET DYNAMICS
  • FIGURE 9. OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. OPHTHALMOLOGY MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. OPHTHALMOLOGY MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. OPHTHALMOLOGY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. OPHTHALMOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. OPHTHALMOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 5. OPHTHALMOLOGY MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. OPHTHALMOLOGY MARKET SIZE, BY CATARACT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. OPHTHALMOLOGY MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. OPHTHALMOLOGY MARKET SIZE, BY REFRACTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 12. OPHTHALMOLOGY MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. OPHTHALMOLOGY MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS & INFLAMMATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. OPHTHALMOLOGY MARKET SIZE, BY DRY EYE DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. OPHTHALMOLOGY MARKET SIZE, BY RETINAL DISORDER DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 18. OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. OPHTHALMOLOGY MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 21. OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. OPHTHALMOLOGY MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. OPHTHALMOLOGY MARKET SIZE, BY OPHTHALMIC LASERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. OPHTHALMOLOGY MARKET SIZE, BY PRESCRIPTION GLASSES & LENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. OPHTHALMOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. OPHTHALMOLOGY MARKET SIZE, BY HEALTHCARE SERVICE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. OPHTHALMOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. OPHTHALMOLOGY MARKET SIZE, BY MEDICAL INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. OPHTHALMOLOGY MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 281. OPHTHALMOLOGY MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 282. OPHTHALMOLOGY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 283. OPHTHALMOLOGY MARKET LICENSE & PRICING
目次
Product Code: MRR-4348D129FA97

The Global Ophthalmology Market is forecasted to grow significantly, with a projected USD 59.90 billion in 2023 at a CAGR of 6.63% and expected to reach a staggering USD 93.99 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Ophthalmology Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Ophthalmology Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Diseases, market is studied across Age-Related Macular Degeneration, Cataract, Glaucoma, Inflammatory Diseases, and Refractive Disorders. The Refractive Disorders commanded largest market share of 35.32% in 2022, followed by Age-Related Macular Degeneration.

Based on Product Type, market is studied across Drugs, Equipment, Prescription Glasses & Lens, and Software. The Drugs is further studied across Allergic Conjunctivitis & Inflammation Drugs, Dry Eye Drugs, Glaucoma Drugs, and Retinal Disorder Drugs. The Equipment is further studied across Diagnostic Devices and Surgical Devices. The Surgical Devices is further studied across Intraocular Lenses and Ophthalmic Lasers. The Prescription Glasses & Lens commanded largest market share of 51.58% in 2022, followed by Drugs.

Based on End User, market is studied across Healthcare Service Providers, Hospitals, Medical Institutes, and Research Organizations. The Hospitals commanded largest market share of 34.34% in 2022, followed by Healthcare Service Providers.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 48.68% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Ophthalmology Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Ophthalmology Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Ophthalmology Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Ophthalmology Market?

4. What is the competitive strategic window for opportunities in the Global Ophthalmology Market?

5. What are the technology trends and regulatory frameworks in the Global Ophthalmology Market?

6. What is the market share of the leading vendors in the Global Ophthalmology Market?

7. What modes and strategic moves are considered suitable for entering the Global Ophthalmology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Ophthalmology Market, by Diseases, 2022 vs 2030
  • 4.3. Ophthalmology Market, by Product Type, 2022 vs 2030
  • 4.4. Ophthalmology Market, by End User, 2022 vs 2030
  • 4.5. Ophthalmology Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of eye disorders and growing awareness among the population
      • 5.1.1.2. Increasing adoption of prescription glasses and lenses
      • 5.1.1.3. Presence of well-equipped healthcare infrastructure and increasing number of drugs approvals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of ophthalmologic treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging research activities of ophthalmology treatments and availability of grants
      • 5.1.3.2. High usage potential owing to the technological integrations in Ophthalmology
    • 5.1.4. Challenges
      • 5.1.4.1. Limited skilled professionals for ophthalmic procedures
  • 5.2. Market Trends
    • 5.2.1. Emergence of telehealth and expansion of ophthalmology care across Americas
    • 5.2.2. Start-ups focusing on developing ophthalmology drugs with increasing need due to prevalence of blindness & vision impairment in Asia-Pacific
    • 5.2.3. Surging research activities and continuous technological advancements in ophthalmology therapeutics in EMEA
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Ophthalmology Market, by Diseases

  • 6.1. Introduction
  • 6.2. Age-Related Macular Degeneration
  • 6.3. Cataract
  • 6.4. Glaucoma
  • 6.5. Inflammatory Diseases
  • 6.6. Refractive Disorders

7. Ophthalmology Market, by Product Type

  • 7.1. Introduction
  • 7.2. Drugs
    • 7.2.1. Allergic Conjunctivitis & Inflammation Drugs
    • 7.2.2. Dry Eye Drugs
    • 7.2.3. Glaucoma Drugs
    • 7.2.4. Retinal Disorder Drugs
  • 7.3. Equipment
    • 7.3.1. Diagnostic Devices
    • 7.3.2. Surgical Devices
      • 7.3.2.1. Intraocular Lenses
      • 7.3.2.2. Ophthalmic Lasers
  • 7.4. Prescription Glasses & Lens
  • 7.5. Software

8. Ophthalmology Market, by End User

  • 8.1. Introduction
  • 8.2. Healthcare Service Providers
  • 8.3. Hospitals
  • 8.4. Medical Institutes
  • 8.5. Research Organizations

9. Americas Ophthalmology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Ophthalmology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Ophthalmology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. Merger & Acquisition
      • 12.3.1.1. Astellas reaches agreement to acquire Iveric Bio for USD 5.9 billion
      • 12.3.1.2. Viatris Forms Eye Care Unit from Acquisitions of Oyster Point Pharma and Famy Life Sciences
    • 12.3.2. Agreement, Collaboration, & Partnership
      • 12.3.2.1. Celanese Announces Agreement with Glaukos Corporation for Sustained Release Glaucoma Treatment
      • 12.3.2.2. Thea Open Innovation and Galimedix announce strategic to develop and commercialize products
      • 12.3.2.3. Grifols enters agreement with Selagine to develop immunoglobulin eye drops to treat dry eye disease
      • 12.3.2.4. Topcon Healthcare and OphtAI Announce their Partnership in EMEA
      • 12.3.2.5. Eyenovia and Formosa partner for new ophthalmic therapeutics
    • 12.3.3. New Product Launch & Enhancement
      • 12.3.3.1. HOYA Vision launches MiYOSMART Sun lenses to protect against myopia in children
      • 12.3.3.2. Bausch + Lomb Announces U.S. Launch of StableVisc Cohesive Ophthalmic Viscosurgical Device and TotalVisc Viscoelastic System
      • 12.3.3.3. NIDEK launches the NT-1/1e Non Contact Tonometer
    • 12.3.4. Investment & Funding
      • 12.3.4.1. Alkeus Announces USD 150 million Series B Financing,
      • 12.3.4.2. AI-based eye disease detection startup, Eyetelligence raises USD 12 million USD from investors
    • 12.3.5. Award, Recognition, & Expansion
      • 12.3.5.1. Curative Biotechnology files patent on ophthalmic formulation
      • 12.3.5.2. Eyenovia Announces Fda Approval Of Mydcombi, The First Ophthalmic Spray For Mydriasis, Which Also Leverages The Company's Proprietary Optejet Device Platform

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing